|
|||||
|
|||||
|
|||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi |
|||||
|
|
||||
1. Identity of the issuer or the underlying issuer |
Deltex Medical Group Plc (Sedol: 3103865) |
||||
2 Reason for the notification (please tick the appropriate box or boxes): |
|||||
An acquisition or disposal of voting rights |
X |
||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
||||
An event changing the breakdown of voting rights |
|
||||
Other (please specify): |
|
|
|||
3. Full name of person(s) subject to the |
Cazenove Capital Management Limited |
||||
4. Full name of shareholder(s) |
N/A |
||||
5. Date of the transaction and date on |
06/05/11 |
||||
6. Date on which issuer notified: |
09/05/11 |
||||
7. Threshold(s) that is/are crossed or |
5% |
||||
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
||||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||||||
GB0059337583
|
6,916,543
|
6,916,543
|
6,879,749 |
0 |
6,879,749 |
0 |
4.99%
|
|||||||||
|
||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||||
N/A |
N/A |
N/A |
N/A |
N/A |
||||||||||||
|
||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Exercise price |
Expiration date xvii |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
|||||||||||
N/A |
N/A |
N/A |
N/A |
N/A |
Nominal |
Delta |
||||||||||
N/A |
N/A |
|||||||||||||||
|
||||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
6,879,749 |
4.99% |
|||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||
N/A |
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
N/A |
|
11. Number of voting rights proxy holder will cease |
N/A |
|
12. Date on which proxy holder will cease to hold |
N/A |
|
|
||
|
|
|
14. Contact name: |
N/A |
|
15. Contact telephone number: |
N/A |
|
Note: Annex should only be submitted to the FSA not the issuer |
|
Annex: Notification of major interests in share |
|
|
|
A: Identity of the persons or legal entity subject to the notification obligation |
|
Full name (including legal form of legal entities)
|
Cazenove Capital Management Limited |
Contact address (registered office for legal entities)
|
12 Moorgate, London, EC2R 6DA |
Phone number & email
|
0203 479 0461 |
Other useful information (at least legal representative for legal persons)
|
Laura Whelan |
|
|
B: Identity of the notifier, if applicable |
|
Full name
|
N/A |
Contact address
|
N/A |
Phone number & email
|
N/A |
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) |
N/A |
|
|
C: Additional information |
|
|
|
For notes on how to complete form TR-1 please see the FSA website. |